Recursion Pharmaceuticals is laying off a fifth of its workforce in connect with a previously announced streamlining of the AI biotech’s pipeline.

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) are tumbling on Tuesday. The move comes as the S&P 500 and Nasdaq Composite both slipped by 0.6%. The data from an April survey revealed Tuesday ...

Recursion Pharmaceuticals stock isn't a good fit for risk-averse investors. The company remains unprofitable and is losing more money as it ramps up clinical development of several candidates.

Recursion's share price has dropped in recent weeks due to poor clinical trial data, but its most mature assets are not reflective of its current capabilities. Read more here.

Recursion has stumbled through an early test of its tech-enabled drug discovery, reporting a hit on safety but failing to wow on the efficacy front.

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request ...

This Java recursion tutorial shows you how to create a recursive Java factorial function and compares these methods to iterative ones.